Side effects of modern vaccines: Why Finland, Sweden has limited use
Finland, Sweden and Denmark announced this week that they will temporarily stop using the Modern COVID-19 vaccine due to a rare cardiovascular side effect, pr Reuters.
- Specifically, the countries received reports of heart problems in younger men.
- Sweden has paused use for those born in 1991 and later. Finland will do the same.
- For Denmark, anyone under the age of 18 can no longer receive the Modern Coronavirus Vaccine.
Per PoliticoThere have recently been a number of data points indicating an increase in myocarditis, an inflammation of the heart muscle and pericarditis, which is inflammation of the pericardium, for those who received the Modern COVID-19 vaccine.
- “The connection is particularly clear when it comes to Moderna’s vaccine Spikevax, especially after the second dose,” says the Swedish Health Authority in a statement.
- But the Swedish agency said, “the risk of being affected is very small.”
For months, questions have been asked about whether or not the coronavirus vaccine can cause inflammation in the heart muscle. Some reports suggest that myocarditis may be a side effect of the COVID-19 vaccine, as Deseret News reported.
Federal health officials – including the Food and Drug Administration and the Centers for Disease Control and Prevention – are now investigating Modern COVID-19 vaccine can cause myocarditis because there were data suggesting that the vaccine “may pose a higher risk” to young people; Washington Post reports.
- Officials will examine whether the Moderna vaccine is linked “to a higher risk of a heart disease called myocarditis in younger adults than previously thought”, according to Washington Post.
But Israeli Ministry of Health said in June that it noticed a small number of cases of myocarditis in younger men who received the vaccine Pfizer COVID-19, which I wrote for Deseret News.
- Pfizer said in another statement The litter: “No causal relationship to the vaccine has been established. With more than 300 million doses of the Pfizer-BioNTech COVID-19 vaccine administered globally, the benefit-risk profile of our vaccine remains positive. ”